Next |
home / stock / cybn / cybn message board
Subject | By | Source | When |
---|---|---|---|
$CYBN The trading up | Nosnibor | investorshub | 04/27/2023 11:57:26 PM |
bears are running | Reyeton | investorshub | 04/27/2023 7:22:01 PM |
$CYBN The now last up | Reyeton | investorshub | 04/27/2023 2:17:05 PM |
MomentumIts trading | sagedono | investorshub | 04/27/2023 2:53:31 AM |
$CYBN what does this mean? | sagedono | investorshub | 04/26/2023 3:14:53 PM |
news all the way baby | Twothreetimes | investorshub | 04/26/2023 1:27:13 PM |
What do you make of this? | Nosnibor | investorshub | 04/26/2023 12:32:45 PM |
$CYBN what do you make of this data? | ListenToMe | investorshub | 04/26/2023 8:45:20 AM |
$CYBN Price gaining last up | PyroStocks | investorshub | 04/26/2023 4:24:01 AM |
$CYBN where is the squeeze? | Investopotia | investorshub | 04/26/2023 4:19:23 AM |
$CYBN and the shorts continue | Nosnibor | investorshub | 04/25/2023 11:46:52 PM |
$CYBN MomentumIts now up | BubbaInSC | investorshub | 04/25/2023 5:15:05 AM |
$CYBN MomentumIts gaining up | Reyeton | investorshub | 04/24/2023 7:54:30 PM |
Price now | Nosnibor | investorshub | 04/24/2023 4:39:24 PM |
$CYBN The gaining | BubbaInSC | investorshub | 04/24/2023 3:50:39 PM |
Price trading | sagedono | investorshub | 04/24/2023 8:40:44 AM |
$CYBN Long and strong lets hope im right | sagedono | investorshub | 04/24/2023 8:11:39 AM |
Price gaining last up | BubbaInSC | investorshub | 04/24/2023 5:09:12 AM |
$CYBN The trading up | Reyeton | investorshub | 04/23/2023 9:54:49 PM |
short squeeze | Reyeton | investorshub | 04/23/2023 7:09:39 PM |
News, Short Squeeze, Breakout and More Instantly...
Cybin (NYSE American: CYBN) (Cboe CA: CYBN) , a clinical-stage biopharmaceutical company committed to revolutionizing mental healthcare by developing new and innovative next-generation treatment options for mental-health disorders, is reporting its audited financial results for the fiscal year en...
- Received U.S. Food and Drug Administration (“FDA”) Breakthrough Therapy Designation (“BTD”) for CYB003, its proprietary deuterated psilocybin analog in development for the adjunctive treatment of Major Depressive Disorder (“MDD”) - - Clinical si...
Cybin (NYSE American: CYBN) (Cboe CA: CYBN) , a clinical-stage biopharmaceutical company committed to revolutionizing mental healthcare by developing new and innovative next-generation, psychedelic-based treatment options, will be spotlighted during an upcoming online fireside chat at the H.C. Wa...